Mereo BioPharma Group plc (Mereo) (MREO) Social Stream
MEREO BIOPHARMA GROUP PLC (MREO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MEREO BIOPHARMA GROUP PLC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-25 | 1 | $10 | $8 | $9 | $2.82 | 219.15% |
| 2022-04-01 | 2 | $8 | $8 | $8 | $2.82 | 183.69% |
| 2022-06-06 | 2 | $8 | $5 | $6.5 | $2.82 | 130.5% |
| 2022-08-12 | 3 | $8 | $4 | $5.666 | $2.82 | 100.92% |
| 2023-09-08 | 3 | $5 | $4 | $4.333 | $2.82 | 53.65% |
| 2023-12-15 | 4 | $5 | $4 | $4.25 | $2.82 | 50.71% |
The Trend in the Analyst Price Target
MREO's average price target has moved down $0 over the prior 63 days.
MREO reports an average of 218.94% for its upside potential over the past 37 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-07-11 | 3 | 5 | 4 | 4.333 | 1.28 | 238.52% |
| 2023-09-08 | 3 | 5 | 4 | 4.333 | 1.41 | 207.3% |
| 2023-10-13 | 4 | 5 | 4 | 4.250 | 1.29 | 229.46% |
| 2023-12-05 | 4 | 5 | 4 | 4.250 | 2.03 | 109.36% |
| 2023-12-15 | 4 | 5 | 4 | 4.250 | 2.05 | 107.32% |
MREO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 3 | 1 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
MREO's average broker recommendation rating improved by 0.08 over the prior 39 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MREO as an investment opportunity.
- In the context of all US stocks, MEREO BIOPHARMA GROUP PLC's number of analysts covering the stock is greater than 57.17% of them.
- In terms of how MEREO BIOPHARMA GROUP PLC fares relative to all US stocks, note that its average analyst price target is greater than 61.06% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MEREO BIOPHARMA GROUP PLC's variance in analysts' estimates is lower than -66.37% of them.
- In terms of how MEREO BIOPHARMA GROUP PLC fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is greater than 569.67% of that group.
Stocks similar to MEREO BIOPHARMA GROUP PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GHSI, HOTH, and SXTC.
View All Top Stocks by Price Target
What is the outlook for MREO? Use POWR Ratings for clearer insight into price direction.